CAR-t – pharmaceutical daily

April 4, 2019 Off

Janssen Announces Investigational CAR-T Therapy JNJ-68284528 Granted PRIME Designation by the European Medicines Agency

PRIME (PRIority MEdicines) designation based on clinical study results evaluating safety and efficacy of novel CAR-T therapy in the treatment…

March 31, 2019 Off

F1 Oncology to Present Data That Expands on Proof of Novel Point of Care Approach for CAR-T Therapies in Solid Tumor Malignancies

By BusinessWire

Data Presented at 2019 AACR Annual Meeting Supports Novel Conditionally Active Biologics CAR-T Technology ATLANTA–(BUSINESS WIRE)–F1 Oncology, Inc., a biotechnology…